share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC ·  Nov 13 00:38

Summary by Futu AI

Arcutis Biotherapeutics, Inc. Director Terrie Curran is set to sell 8,687 shares of common stock on 11/11/2024, with an aggregate market value of $94,238. The shares to be sold were acquired through restricted stock vests on two separate occasions, with 4,312 shares acquired on 06/01/2023 and an additional 4,375 shares on 05/31/2024. The company has not reported any other securities transactions by Curran in the past three months.
Arcutis Biotherapeutics, Inc. Director Terrie Curran is set to sell 8,687 shares of common stock on 11/11/2024, with an aggregate market value of $94,238. The shares to be sold were acquired through restricted stock vests on two separate occasions, with 4,312 shares acquired on 06/01/2023 and an additional 4,375 shares on 05/31/2024. The company has not reported any other securities transactions by Curran in the past three months.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated